John Mascola, ModeX Therapeutics CSO

Ex-Warp Speed vac­cine leader nabs NextGen funds for Mod­eX Ther­a­peu­tics’ Covid-19 an­ti­bod­ies

A for­mer leader of Op­er­a­tion Warp Speed’s vac­cines ef­fort, which led to a quick roll­out of Covid jabs, is get­ting fed­er­al fund­ing for his biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.